These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15132682)

  • 1. Tailoring of bioresorbable polymers for elaboration of sugar-functionalized nanoparticles.
    Cade D; Ramus E; Rinaudo M; Auzély-Velty R; Delair T; Hamaide T
    Biomacromolecules; 2004; 5(3):922-7. PubMed ID: 15132682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step preparation of poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanoparticles for plasmid DNA delivery.
    Huang MJ; Gou ML; Qian ZY; Dai M; Li XY; Cao M; Wang K; Zhao J; Yang JL; Lu Y; Tu MJ; Wei YQ
    J Biomed Mater Res A; 2008 Sep; 86(4):979-86. PubMed ID: 18067161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of the biodegradable polycaprolactone-graft-chitosan amphiphilic copolymers.
    Yu H; Wang W; Chen X; Deng C; Jing X
    Biopolymers; 2006 Oct; 83(3):233-42. PubMed ID: 16761262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface property and in vitro biodegradation of microspheres fabricated by poly(epsilon-caprolactone-b-ethylene oxide) diblock copolymers.
    Yu G; Zhang Y; Shi X; Li Z; Gan Z
    J Biomed Mater Res A; 2008 Mar; 84(4):926-39. PubMed ID: 17647229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
    Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
    J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannosylated poly(ethylene oxide)-b-poly(epsilon-caprolactone) diblock copolymers: synthesis, characterization, and interaction with a bacterial lectin.
    Rieger J; Stoffelbach F; Cui D; Imberty A; Lameignere E; Putaux JL; Jérôme R; Jérôme C; Auzély-Velty R
    Biomacromolecules; 2007 Sep; 8(9):2717-25. PubMed ID: 17705426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.
    Lince F; Marchisio DL; Barresi AA
    J Colloid Interface Sci; 2008 Jun; 322(2):505-15. PubMed ID: 18402975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone.
    Zhang Y; Zhuo RX
    Biomaterials; 2005 Nov; 26(33):6736-42. PubMed ID: 15935469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and surface modification of poly(ester-anhydride) micro- and nanospheres.
    Pfeifer BA; Burdick JA; Langer R
    Biomaterials; 2005 Jan; 26(2):117-24. PubMed ID: 15207458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biodegradable copolyesters containing blocks of poly(3-hydroxyoctanoate) and poly(epsilon-caprolactone): synthesis and characterization.
    Timbart L; Renard E; Langlois V; Guerin P
    Macromol Biosci; 2004 Nov; 4(11):1014-20. PubMed ID: 15540249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.
    Shenoy DB; Amiji MM
    Int J Pharm; 2005 Apr; 293(1-2):261-70. PubMed ID: 15778064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, effect of architecture on crystallization of biodegradable poly(epsilon-caprolactone)-b-poly(ethylene oxide) copolymers with different arms and nanoparticles thereof.
    Hua C; Dong CM
    J Biomed Mater Res A; 2007 Sep; 82(3):689-700. PubMed ID: 17323321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model.
    Beck-Broichsitter M; Gauss J; Packhaeuser CB; Lahnstein K; Schmehl T; Seeger W; Kissel T; Gessler T
    Int J Pharm; 2009 Feb; 367(1-2):169-78. PubMed ID: 18848609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel amphiphilic poly(epsilon-caprolactone)-g-poly(L-lysine) degradable copolymers.
    Nottelet B; El Ghzaoui A; Coudane J; Vert M
    Biomacromolecules; 2007 Aug; 8(8):2594-601. PubMed ID: 17625909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
    Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
    J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supramolecular and biomimetic polypseudorotaxane/glycopolymer biohybrids: synthesis, glucose-surfaced nanoparticles, and recognition with lectin.
    Dai XH; Dong CM; Yan D
    J Phys Chem B; 2008 Mar; 112(12):3644-52. PubMed ID: 18318528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of phosphoryl-choline-capped poly(epsilon-caprolactone)-poly(ethylene oxide) di-block co-polymers and its surface modification on polyurethanes.
    Zhang T; Song Z; Chen H; Yu X; Jiang Z
    J Biomater Sci Polym Ed; 2008; 19(4):509-24. PubMed ID: 18318962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.